Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Does salt stress constrain spatial distribution of dune building grasses Ammophila arenaria and Elytrichia juncea on the beach?

van Puijenbroek MEB, Teichmann C, Meijdam N, Oliveras I, Berendse F, Limpens J.

Ecol Evol. 2017 Aug 8;7(18):7290-7303. doi: 10.1002/ece3.3244. eCollection 2017 Sep.

2.

Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.

Middeldorp A, van Eijk R, Oosting J, Forte GI, van Puijenbroek M, van Nieuwenhuizen M, Corver WE, Ruano D, Caldes T, Wijnen J, Morreau H, van Wezel T.

Int J Cancer. 2012 Feb 15;130(4):837-46. doi: 10.1002/ijc.26093. Epub 2011 Jul 15.

3.

Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer.

van Roon EH, de Miranda NF, van Nieuwenhuizen MP, de Meijer EJ, van Puijenbroek M, Yan PS, Huang TH, van Wezel T, Morreau H, Boer JM.

Eur J Hum Genet. 2011 Mar;19(3):307-12. doi: 10.1038/ejhg.2010.187. Epub 2010 Dec 8.

4.

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

van Roon EH, van Puijenbroek M, Middeldorp A, van Eijk R, de Meijer EJ, Erasmus D, Wouters KA, van Engeland M, Oosting J, Hes FJ, Tops CM, van Wezel T, Boer JM, Morreau H.

BMC Cancer. 2010 May 5;10:180. doi: 10.1186/1471-2407-10-180.

5.

Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.

Middeldorp A, Jagmohan-Changur SC, van der Klift HM, van Puijenbroek M, Houwing-Duistermaat JJ, Webb E, Houlston R, Tops C, Vasen HF, Devilee P, Morreau H, van Wezel T, Wijnen J.

Genes Chromosomes Cancer. 2010 Jun;49(6):539-48. doi: 10.1002/gcc.20763.

PMID:
20222047
6.

Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues.

van Eijk R, van Puijenbroek M, Chhatta AR, Gupta N, Vossen RH, Lips EH, Cleton-Jansen AM, Morreau H, van Wezel T.

J Mol Diagn. 2010 Jan;12(1):27-34. doi: 10.2353/jmoldx.2010.090028. Epub 2009 Dec 3.

7.

Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas.

Nielsen M, de Miranda NF, van Puijenbroek M, Jordanova ES, Middeldorp A, van Wezel T, van Eijk R, Tops CM, Vasen HF, Hes FJ, Morreau H.

BMC Cancer. 2009 Jun 15;9:184. doi: 10.1186/1471-2407-9-184.

8.

MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.

de Miranda NF, Nielsen M, Pereira D, van Puijenbroek M, Vasen HF, Hes FJ, van Wezel T, Morreau H.

J Pathol. 2009 Sep;219(1):69-76. doi: 10.1002/path.2569.

PMID:
19462419
9.

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.

Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, Cornelisse CJ, Fleuren GJ, Morreau H, Oosting J, van Wezel T.

Cancer Res. 2008 Dec 15;68(24):10333-40. doi: 10.1158/0008-5472.CAN-08-2665.

10.

Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.

Wijnen JT, Brohet RM, van Eijk R, Jagmohan-Changur S, Middeldorp A, Tops CM, van Puijenbroek M, Ausems MG, Gómez García E, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Verhoef S, Wagner A, Nagengast FM, Kleibeuker JH, Devilee P, Morreau H, Goldgar D, Tomlinson IP, Houlston RS, van Wezel T, Vasen HF.

Gastroenterology. 2009 Jan;136(1):131-7. doi: 10.1053/j.gastro.2008.09.033. Epub 2008 Sep 25.

PMID:
19010329
11.

High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas.

Middeldorp A, van Puijenbroek M, Nielsen M, Corver WE, Jordanova ES, ter Haar N, Tops CM, Vasen HF, Lips EH, van Eijk R, Hes FJ, Oosting J, Wijnen J, van Wezel T, Morreau H.

J Pathol. 2008 Sep;216(1):25-31. doi: 10.1002/path.2375.

PMID:
18506705
12.

Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.

van Puijenbroek M, Middeldorp A, Tops CM, van Eijk R, van der Klift HM, Vasen HF, Wijnen JT, Hes FJ, Oosting J, van Wezel T, Morreau H.

Fam Cancer. 2008;7(4):319-30. doi: 10.1007/s10689-008-9194-8. Epub 2008 Apr 15.

PMID:
18415027
13.

Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumours.

Dierssen JW, van Puijenbroek M, Dezentjé DA, Fleuren GJ, Cornelisse CJ, van Wezel T, Offringa R, Morreau H.

Eur J Hum Genet. 2008 Oct;16(10):1235-9. doi: 10.1038/ejhg.2008.81. Epub 2008 Apr 16.

14.

Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.

van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H.

Clin Cancer Res. 2008 Jan 1;14(1):139-42. doi: 10.1158/1078-0432.CCR-07-1705.

15.

Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.

Sánchez-de-Abajo A, de la Hoya M, van Puijenbroek M, Tosar A, López-Asenjo JA, Díaz-Rubio E, Morreau H, Caldes T.

Clin Cancer Res. 2007 Oct 1;13(19):5729-35.

16.

Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.

Haven CJ, van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, van Wezel T, Morreau H.

Clin Endocrinol (Oxf). 2007 Sep;67(3):370-6. Epub 2007 Jun 6.

PMID:
17555500
17.

HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.

Dierssen JW, de Miranda NF, Ferrone S, van Puijenbroek M, Cornelisse CJ, Fleuren GJ, van Wezel T, Morreau H.

BMC Cancer. 2007 Feb 22;7:33.

18.

The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.

van Puijenbroek M, Nielsen M, Reinards TH, Weiss MM, Wagner A, Hendriks YM, Vasen HF, Tops CM, Wijnen J, van Wezel T, Hes FJ, Morreau H.

Fam Cancer. 2007;6(1):43-51.

PMID:
17039270
19.

High-resolution analysis of HLA class I alterations in colorectal cancer.

Dierssen JW, de Miranda NF, Mulder A, van Puijenbroek M, Verduyn W, Claas FH, van de Velde CJ, Jan Fleuren G, Cornelisse CJ, Corver WE, Morreau H.

BMC Cancer. 2006 Oct 2;6:233.

20.

Duodenal carcinoma in MUTYH-associated polyposis.

Nielsen M, Poley JW, Verhoef S, van Puijenbroek M, Weiss MM, Burger GT, Dommering CJ, Vasen HF, Kuipers EJ, Wagner A, Morreau H, Hes FJ.

J Clin Pathol. 2006 Nov;59(11):1212-5. Epub 2006 Aug 30.

21.

Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

Hendriks YM, Jagmohan-Changur S, van der Klift HM, Morreau H, van Puijenbroek M, Tops C, van Os T, Wagner A, Ausems MG, Gomez E, Breuning MH, Bröcker-Vriends AH, Vasen HF, Wijnen JT.

Gastroenterology. 2006 Feb;130(2):312-22.

PMID:
16472587
22.

Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer?

Sanchez de Abajo A, de la Hoya M, van Puijenbroek M, Godino J, Díaz-Rubio E, Morreau H, Caldes T.

Oncogene. 2006 Mar 30;25(14):2124-30.

PMID:
16288214
24.

Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.

van Puijenbroek M, van Asperen CJ, van Mil A, Devilee P, van Wezel T, Morreau H.

J Pathol. 2005 Jun;206(2):198-204.

PMID:
15818573
25.

Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.

Vasen HF, Hendriks Y, de Jong AE, van Puijenbroek M, Tops C, Bröcker-Vriends AH, Wijnen JT, Morreau H.

Dis Markers. 2004;20(4-5):207-13. Review.

26.

Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.

Haven CJ, Howell VM, Eilers PH, Dunne R, Takahashi M, van Puijenbroek M, Furge K, Kievit J, Tan MH, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Dralle H, Hoang-Vu C, Gimm O, Morreau H, Marsh DJ, Teh BT.

Cancer Res. 2004 Oct 15;64(20):7405-11.

27.

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Bröcker-Vriends AH, Vasen H.

Gastroenterology. 2004 Jul;127(1):17-25.

PMID:
15236168
28.

Extending the p16-Leiden tumour spectrum by respiratory tract tumours.

Oldenburg RA, de Vos tot Nederveen Cappel WH, van Puijenbroek M, van den Ouweland A, Bakker E, Griffioen G, Devilee P, Cornelisse CJ, Meijers-Heijboer H, Vasen HF, Morreau H.

J Med Genet. 2004 Mar;41(3):e31. No abstract available.

29.

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.

de Jong AE, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems MG, Meijers-Heijboer H, Wagner A, van Os TA, Bröcker-Vriends AH, Vasen HF, Morreau H.

Clin Cancer Res. 2004 Feb 1;10(3):972-80.

30.

The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.

De Jong AE, Morreau H, Van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM, Griffioen G, Cats A, Menko FH, Kleibeuker JH, Vasen HF.

Gastroenterology. 2004 Jan;126(1):42-8.

PMID:
14699485
31.

Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.

Haven CJ, van Puijenbroek M, Karperien M, Fleuren GJ, Morreau H.

J Pathol. 2004 Jan;202(1):86-94.

PMID:
14694525
32.

Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).

de vos tot Nederveen Cappel WH, Offerhaus GJ, van Puijenbroek M, Caspers E, Gruis NA, De Snoo FA, Lamers CB, Griffioen G, Bergman W, Vasen HF, Morreau H.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3598-605.

33.

Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R.

Am J Hum Genet. 2003 May;72(5):1088-100. Epub 2003 Mar 25.

34.

Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014-1019, 2002.

de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H.

Cancer Res. 2003 Mar 1;63(5):1148-9. No abstract available.

35.

Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.

Menon AG, Morreau H, Tollenaar RA, Alphenaar E, Van Puijenbroek M, Putter H, Janssen-Van Rhijn CM, Van De Velde CJ, Fleuren GJ, Kuppen PJ.

Lab Invest. 2002 Dec;82(12):1725-33.

PMID:
12480922
36.

Bias in detection of instability of the (C)8 mononucleotide repeat of MSH6 in tumours from HNPCC patients.

de Leeuw WJ, van Puijenbroek M, Merx R, Wijnen JT, Bröcker-Vriends AH, Tops C, Vasen H, Cornelisse CJ, Morreau H.

Oncogene. 2001 Sep 27;20(43):6241-4.

37.

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.

Laman JD, Maassen CB, Schellekens MM, Visser L, Kap M, de Jong E, van Puijenbroek M, van Stipdonk MJ, van Meurs M, Schwärzler C, Günthert U.

Mult Scler. 1998 Jun;4(3):147-53.

PMID:
9762665
38.

[Organ donation in a general hospital].

van der Werken C, van Hellenberg Hubar P, Leyten AC, van Puijenbroek MJ, van de Vecht EC, van Vroonhoven TJ.

Ned Tijdschr Geneeskd. 1990 Aug 18;134(33):1601-3. Dutch.

PMID:
2395486

Supplemental Content

Loading ...
Support Center